Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving β-blockers
- 1 December 2004
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 23 (12), 1414-1422
- https://doi.org/10.1016/j.healun.2003.10.002
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJournal of the American College of Cardiology, 2001
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathyAmerican Heart Journal, 2001
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant EvaluationCirculation, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatmentJournal of the American College of Cardiology, 1994
- Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failureJournal of the American College of Cardiology, 1991
- Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathyAmerican Heart Journal, 1990